Beta Bionics Inc. Revenue 2023–2025
Beta Bionics Inc. annual/quarterly revenue history and growth rate from 2023 to 2026. Revenue can be defined as the amount of money a company receives from its customers in exchange for the sale of goods or services. Revenue is the top line item on an income statement from which all costs and expenses are subtracted to arrive at net income.
- Beta Bionics Inc. revenue for the quarter ending March 31, 2026 was 27.6 M, a 56.62% increase year-over-year.
- Beta Bionics Inc. revenue for the twelve months ending March 31, 2026 was 95.8 M.
- Beta Bionics Inc. annual revenue for 2025 was 100.3 M, a 53.94% increase from 2024.
- Beta Bionics Inc. annual revenue for 2024 was 65.1 M, a 442.93% increase from 2023.
- Beta Bionics Inc. annual revenue for 2023 was 12.0 M.
Beta Bionics Inc. (BBNX) — Frequently Asked Questions
Beta Bionics Inc. (BBNX) is a publicly traded US company. It has a market capitalization of $587M. In fiscal 2025 it reported revenue of $100M and net income of -$73M. Explore BBNX's stock price, financial statements, earnings history, margins and key ratios below.
What is Beta Bionics Inc.'s market cap?
Beta Bionics Inc. (BBNX) has a market capitalization of $587M.
What is the BBNX stock price?
BBNX trades at $14.49 (+5.61% on the day).
How much revenue does Beta Bionics Inc. make?
Beta Bionics Inc. reported revenue of $100M in fiscal 2025.
Is BBNX profitable?
In fiscal 2025, Beta Bionics Inc. reported net income of -$73M.